Malignant solid neoplasm Trials in Los Angeles, United States
Conditions / Malignant solid neoplasm / Los Angeles, United States
Malignant solid neoplasm is a medical condition with active clinical research programs worldwide.
27 total trials for this combination
Showing top 10 of 27 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT05103358 | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | ACTIVE_NOT_RECRUITING | — |